Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ciprian Catana, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Ciprian Catana and Bruce Rosen.
Connection Strength

3.907
  1. PET and MR imaging: the odd couple or a match made in heaven? J Nucl Med. 2013 May; 54(5):815-24.
    View in: PubMed
    Score: 0.547
  2. PET/MRI for neurologic applications. J Nucl Med. 2012 Dec; 53(12):1916-25.
    View in: PubMed
    Score: 0.534
  3. DeepStrain: A Deep Learning Workflow for the Automated Characterization of Cardiac Mechanics. Front Cardiovasc Med. 2021; 8:730316.
    View in: PubMed
    Score: 0.246
  4. Implementation and Validation of a Three-dimensional Cardiac Motion Estimation Network. Radiol Artif Intell. 2019 Jul 17; 1(4):e180080.
    View in: PubMed
    Score: 0.212
  5. Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo). Eur J Nucl Med Mol Imaging. 2018 11; 45(12):2147-2154.
    View in: PubMed
    Score: 0.198
  6. An Efficient Approach to Perform MR-assisted PET Data Optimization in Simultaneous PET/MR Neuroimaging Studies. J Nucl Med. 2018 Jun 22.
    View in: PubMed
    Score: 0.197
  7. Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation. J Cereb Blood Flow Metab. 2019 01; 39(1):131-146.
    View in: PubMed
    Score: 0.186
  8. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast. Int J Oncol. 2017 Jul; 51(1):281-288.
    View in: PubMed
    Score: 0.183
  9. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype. Br J Cancer. 2017 Mar 28; 116(7):893-902.
    View in: PubMed
    Score: 0.180
  10. An overview of PET/MR, focused on clinical applications. Abdom Radiol (NY). 2017 02; 42(2):631-644.
    View in: PubMed
    Score: 0.179
  11. Dopamine D1 signaling organizes network dynamics underlying working memory. Sci Adv. 2016 06; 2(6):e1501672.
    View in: PubMed
    Score: 0.171
  12. Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med. 2010 Sep; 51(9):1431-8.
    View in: PubMed
    Score: 0.115
  13. An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases. Eur J Nucl Med Mol Imaging. 2021 05; 48(5):1522-1537.
    View in: PubMed
    Score: 0.059
  14. Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa157.
    View in: PubMed
    Score: 0.058
  15. Blood Oxygen Level-Dependent MRI of the Myocardium with Multiecho Gradient-Echo Spin-Echo Imaging. Radiology. 2020 03; 294(3):538-545.
    View in: PubMed
    Score: 0.055
  16. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1871-1884.
    View in: PubMed
    Score: 0.054
  17. Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma. Clin Cancer Res. 2020 01 01; 26(1):206-212.
    View in: PubMed
    Score: 0.054
  18. Imaging of glia activation in people with primary lateral sclerosis. Neuroimage Clin. 2018; 17:347-353.
    View in: PubMed
    Score: 0.047
  19. Functional Characterization of 5-HT1B Receptor Drugs in Nonhuman Primates Using Simultaneous PET-MR. J Neurosci. 2017 11 01; 37(44):10671-10678.
    View in: PubMed
    Score: 0.047
  20. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR. Abdom Radiol (NY). 2017 04; 42(4):1141-1151.
    View in: PubMed
    Score: 0.045
  21. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology. 2016 Dec 13; 87(24):2554-2561.
    View in: PubMed
    Score: 0.044
  22. Multimodality imaging and mathematical modelling of drug delivery to glioblastomas. Interface Focus. 2016 Oct 06; 6(5):20160039.
    View in: PubMed
    Score: 0.044
  23. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdom Radiol (NY). 2016 07; 41(7):1338-48.
    View in: PubMed
    Score: 0.043
  24. Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI. Neuropsychopharmacology. 2016 Apr; 41(5):1427-36.
    View in: PubMed
    Score: 0.041
  25. Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction. Abdom Imaging. 2015 Aug; 40(6):1374-86.
    View in: PubMed
    Score: 0.040
  26. Effects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model. EJNMMI Phys. 2015 Dec; 2(1):6.
    View in: PubMed
    Score: 0.039
  27. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin. 2015; 7:409-14.
    View in: PubMed
    Score: 0.039
  28. Evidence for brain glial activation in chronic pain patients. Brain. 2015 Mar; 138(Pt 3):604-15.
    View in: PubMed
    Score: 0.039
  29. Simultaneous fMRI-PET of the opioidergic pain system in human brain. Neuroimage. 2014 Nov 15; 102 Pt 2:275-82.
    View in: PubMed
    Score: 0.038
  30. A 31-channel MR brain array coil compatible with positron emission tomography. Magn Reson Med. 2015 Jun; 73(6):2363-75.
    View in: PubMed
    Score: 0.037
  31. Dynamic functional imaging of brain glucose utilization using fPET-FDG. Neuroimage. 2014 Oct 15; 100:192-9.
    View in: PubMed
    Score: 0.037
  32. Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A. 2013 Jul 02; 110(27):11169-74.
    View in: PubMed
    Score: 0.035
  33. A receptor-based model for dopamine-induced fMRI signal. Neuroimage. 2013 Jul 15; 75:46-57.
    View in: PubMed
    Score: 0.034
  34. Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model. PLoS One. 2011 Mar 03; 6(3):e17228.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.